which companies make glp-1 drugs 2025’s Breakthrough Obesity Treatments: Top & Innovations 3 Companies at the Forefront

Our compounded medications are not affiliated with, nor endorsed by, Eli Lilly or Novo Nordisk, and are not reviewed by the FDA for safety or efficacy

Alegeus and Empower partner on health-financial solutions

patients will pay close to international prices for these medications

We recently put together an agreement in South Carolina and now some other states, where the private insurers and Medicaid and Medicare pay for sickle cell anemia treatment. That treatment is a million dollars. It cures sickle cell anemia, but its a million dollars. If we can get a generic drug, a biosimilar, that does the exact same thing for a fraction of the cost, we can make that treatment available in every state. Right now, it is barely economic for the insurance companies because they think that maybe the long-term treatment of somebody with sickle cell anemia is going to cost more than that million dollars and it's right on the borderline. If we could cut that in half, it would be a no-brainer for every single state to adopt it. To view or add a comment, sign in Cigna Healthcare recently announced it will eliminate prescription drug rebates in many commercial health plans starting in 2027, expanding to Express Scripts clients in 2028

Further escalation to 2-2.4 mg daily follows after another 2-4 weeks if needed

At least for sitagliptin, it is also known that it lowers the level of free fatty acids (FFA) and thereby also comprises insulin-sensitizing properties (98)